Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort.
Aebersold H, Foster-Witassek F, Aeschbacher S, Beer JH, Blozik E, Blum M, Bonati L, Conte G, Coslovsky M, De Perna ML, Di Valentino M, Felder S, Huber CA, Moschovitis G, Mueller A, Paladini RE, Reichlin T, Rodondi N, Stauber A, Sticherling C, Szucs TD, Conen D, Kuhne M, Osswald S, Schwenkglenks M, Serra-Burriel M; Swiss-AF Investigators.
Aebersold H, et al. Among authors: beer jh.
Open Heart. 2024 Jan 31;11(1):e002567. doi: 10.1136/openhrt-2023-002567.
Open Heart. 2024.
PMID: 38302139
Free PMC article.
Clinical Trial.